Comparison of next‐generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutations

Comparison of next‐generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutations

Abstract Background As the number of genetic mutations that must be tested increases, the Oncomine Dx Target test (ODxTT), which can simultaneously detect multiple cancer‐related genes is becoming the main test used in preference to single‐molecule testing. In this study, we evaluated the performanc...

Full description

Bibliographic Details
Main Authors: Shuji Murakami, Tomoyuki Yokose, Kanako Shinada, Testuya Isaka, Kengo Katakura, Ryouta Ushio, Tetsuro Kondo, Terufumi Kato, Hiroyuki Ito, Haruhiro Saito
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Thoracic Cancer
Subjects:
cobas EGFR mutation test v2
epidermal growth factor receptor gene (EGFR) mutation
next‐generation sequencing
non‐small cell lung cancer
oncomine dx target test
Online Access:https://doi.org/10.1111/1759-7714.14685

Internet

https://doi.org/10.1111/1759-7714.14685

Similar Items